Table 1 Clinical and laboratory data of SLE patients
Parameters | Patients group n = 30 |
|---|---|
N (%) | |
Mucocutaneous manifestations (photosensitivity, malar rash, chronic cutaneous rash, non-scarring alopecia, nasal or oral ulcers) | 19 (63.3%) |
Hematological disorders (thrombocytopenia, leucopenia, lymphopenia, hemolytic anemia) | 18 (60%) |
Renal disorders (hematuria, proteinuria, pyuria, casts) | 17 (56.6%) |
Neurological disorders (seizure, psychosis, cerebrovascular accident, peripheral neuropathy, lupus headache) | 11 (36.6%) |
Arthritis | 10 (33.3 %) |
Serositis | 8 (26.6 %) |
Cardiac involvement (pericardial effusion, valvular affection) | 6(20%) |
Pulmonary disorders (pleurisy, pulmonary hypertension, pneumonitis) | 5 (16.7 %) |
Positive ANA | 30 (100%) |
Positive anti-dsDNA | 19 (63.3%) |
Positive APL antibodies | 6 (20%) |
SLEDAI (mean ± SD) | 11.1 ± 5.2 |
SLICC/ACR (mean ± SD) | 1.2 ± 0.99 |